APA (7th ed.) Citation

Haya M. Almalag, Shiekha S. Alaujan, Hawazin S. Alhazzani, Lamia A. Alzamel, Reem S. Tashkandi, Hussain F. Alarfaj, . . . Mohammed A. Omair. (2022). Prevalence of adverse reactions to intravenously administered originator biologics in patients with rheumatoid arthritis: A 5-year retrospective study. Elsevier.

Chicago Style (17th ed.) Citation

Haya M. Almalag, Shiekha S. Alaujan, Hawazin S. Alhazzani, Lamia A. Alzamel, Reem S. Tashkandi, Hussain F. Alarfaj, Abdurhman S. Alarfaj, and Mohammed A. Omair. Prevalence of Adverse Reactions to Intravenously Administered Originator Biologics in Patients with Rheumatoid Arthritis: A 5-year Retrospective Study. Elsevier, 2022.

MLA (9th ed.) Citation

Haya M. Almalag, et al. Prevalence of Adverse Reactions to Intravenously Administered Originator Biologics in Patients with Rheumatoid Arthritis: A 5-year Retrospective Study. Elsevier, 2022.